Loading
Ovarian Cancer / Breast Cancer / Uterine Cancer · Observational Study
ClinicalTrials.gov · September 8, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a prospective observational study registered to establish a tissue repository and biobank for future genomic research in patients with breast cancer and other gynecologic malignancies. No clinical outcomes or genomic results are reported in this registry record; the study collects biological samples (blood, urine, tumor tissue) and documents medical and family history for downstream analysis.
Observational. Breast Cancer, Ovarian Cancer, Uterine Cancer; age from 18 Years; accepts healthy volunteers. Intervention: Patient Relatives; Patients. n = 500. 1 site: United States.
This is a prospective observational study registered to establish a tissue repository and biobank for future genomic research in patients with breast cancer and other gynecologic malignancies. No clinical outcomes or genomic results are reported in this registry record; the study collects biological samples (blood, urine, tumor tissue) and documents medical and family history for downstream analysis.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This biobank study generates a resource for future translational and genomic research; it does not itself provide clinical evidence on treatment efficacy or outcomes. Clinicians should understand this as a specimen collection effort whose clinical value depends on the quality and scope of future analyses performed on the banked samples.
This is a prospective observational tissue repository and biobank study with no results reported; it documents planned enrollment and collection procedures for future genomic research.
As stated by the source record.
Quoted from the source exactly as published.
This biobank study generates a resource for future translational and genomic research; it does not itself provide clinical evidence on treatment efficacy or outcomes. Clinicians should understand this as a specimen collection effort whose clinical value depends on the quality and scope of future analyses performed on the banked samples.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT03762733). This is a study registration, not published results. Lead sponsor: National Cancer Institute (NCI). Recruitment status: ENROLLING_BY_INVITATION. Study type: OBSERVATIONAL. Enrollment: 500 participants (ESTIMATED). Conditions: Breast Cancer, Ovarian Cancer, Uterine Cancer. Primary outcome measures: Establishment of a tissue repository for the collection and banking of tissue samples , at study completion. Brief summary: Background: A person s blood, tissue, and other samples contain DNA. Cancer is a disease of cells that are not working properly. It is caused by changes in DNA that build up. Researchers want to do future studies on DNA changes This may help them learn how to guide treatment for cancer. They need biological samples like tumors, blood, and urine for these studies. Objective: To create a place to collect and store biological samples from people with gynecologic malignancies like breast cancer. Samples from certain relatives of theirs will be collected too. Eligibility: Adults ages 18 and older who are being seen at NIH for breast cancer or other gynecologic malignancy Their biological relatives of the same age Design: Participants will answer questions about their family history. Participants will have a physical exam and medical history. This will include questions about age, ethnicity, and disease history. They will also answer questions about their medical treatments and responses. Participants will give blood and urine samples. Participants may give a tumor tissue sample. This will not be taken specifically for this study. It will be from a previous procedure or one that is already planned. Other samples may be taken only if a procedure is required for treatment. These include bone marrow, cerebrospinal fluid, and other fluids. A group of doctors and other professionals will oversee the sample storage place. The group will review all requests to be sure the use of the specimens is valid.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.